NeoPhore is turning cold tumors hot by inhibiting DNA mismatch repair to produce more of the neoantigens that trigger immune attack.
| Status | Active |
| Website | https://www.neophore.com/ |
| Category | Biotech |
| Modality | Small Molecule |
| Headquarters | Cambridge, UK |
| Partner | Phoremost |
| Investment Portfolio | Pre-Fund Investment |
| Co-Investors | Parkwalk Sixth Element |